PURCHASE AGREEMENT dated as of May 15, 2017 by and between THERMO FISHER SCIENTIFIC INC., THERMO FISHER (CN) LUXEMBOURG S.À R.L. and PATHEON N.V.Purchase Agreement • May 31st, 2017 • Patheon N.V. • Pharmaceutical preparations • Delaware
This PURCHASE AGREEMENT (this “Agreement”) dated as of May 15, 2017, by and between Thermo Fisher Scientific Inc., a Delaware corporation (“Parent”), Thermo Fisher (CN) Luxembourg S.à r.l., a private limited liability company (société à responsabilité limitée) organized under the Laws of the Grand Duchy of Luxembourg and a wholly-owned subsidiary of Parent (“Buyer”), and Patheon N.V., a public limited liability company (naamloze vennootschap) organized under the Laws of The Netherlands (the “Company”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 31st, 2017 • Patheon N.V. • Pharmaceutical preparations • North Carolina
This Employment Agreement (the “Agreement”) is made as of August 15, 2011 (the “Effective Date”), between Patheon Pharmaceuticals Services Inc. (the “Company”) and Rebecca Holland New (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 31st, 2017 • Patheon N.V. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made as of July 11, 2016 (the “Effective Date”), between Patheon Pharmaceutical Services Inc. (the “Company”) and Craig Schneier (the “Executive”).
RESTRICTED SHARE UNIT AWARD AGREEMENT UNDER THE PATHEON N.V.Restricted Share Unit Award Agreement • May 31st, 2017 • Patheon N.V. • Pharmaceutical preparations • New York
This Award Agreement (this “RSU Award Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Patheon N.V., a Dutch public limited company (the “Company”), and [ ] (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Patheon N.V. 2016 Omnibus Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
OPTION AGREEMENT UNDER THE PATHEON N.V.Option Agreement • May 31st, 2017 • Patheon N.V. • Pharmaceutical preparations • New York
This Award Agreement (this “Option Award Agreement”), dated as of July 20, 2016 (the “Date of Grant”), is made by and between Patheon N.V., a Dutch public limited company (the “Company”), and Mr. Michel Lagarde (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Patheon N.V. 2016 Omnibus Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
OPTION AGREEMENT UNDER THE PATHEON N.V.Option Agreement • May 31st, 2017 • Patheon N.V. • Pharmaceutical preparations • New York
This Award Agreement (this “Option Award Agreement”), dated as of [ ] (the “Date of Grant”), is made by and between Patheon N.V., a Dutch public limited company (the “Company”), and [ ] (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Patheon N.V. 2016 Omnibus Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • May 31st, 2017 • Patheon N.V. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”), created on December 21, 2016, supersedes any previously presented versions and is made as of January 16, 2017, between Patheon Pharmaceutical Services Inc. (the “Company”) and Raul Cardona Torres (the “Executive”).
